Table:
begin	end	state
1	12	non-cytoplasmic
13	80	transmembrane
81	108	non-cytoplasmic
109	135	transmembrane
136	137	non-cytoplasmic
138	146	cytoplasmic
147	163	transmembrane
164	168	non-cytoplasmic
169	188	transmembrane
189	199	cytoplasmic
200	223	transmembrane
224	257	non-cytoplasmic
258	258	cytoplasmic
259	280	transmembrane
281	315	cytoplasmic
316	337	transmembrane
338	355	non-cytoplasmic
356	381	transmembrane
382	390	cytoplasmic
391	409	transmembrane
410	418	non-cytoplasmic
419	444	transmembrane
445	463	cytoplasmic
464	488	transmembrane
489	505	non-cytoplasmic

Input:
>WP_011842395.1 NCBI__GCF_000015985.1:WP_011842395.1
MGTFDFLLQGLAVALDPMILLYALVGVTLGTAVGVLPGIGPALTVALLLPVTYGLDPAGS
LIMFAGIYYGGMYGGSTTSILLNTPGESASIVTALEGNKMARAGRGGPALATAAIGSFVA
GLLATIALALIAPTVVKLALVFGPREYFALMVLAFVTVSAAFGDSTLRGLTSLFIGLALA
VVGIDQLTGQARLSFGVPQLLDGIEVTTLAVALFAVGEALFVAGRGMHRDDEAIAVKGSL
WMTAQDWARSWKSWLRGTVIGFPIGAMPAGGADIASFLSYATEKRFSRHPEEFGHGAIEG
VAGPEAANNASAAGTLVPLLTLGLPTTATAAIMLAGFQQFGLQPGPLLFATNPQLVWGLI
ASLLIANVMLLVLNLPLIGLWVRLLTIPRPWLYAGILLFATLGTIGVNPSPVELGMLLGF
GVLGYLMRLFSYPIAPVVVGLILGPMAEQQLRRALAIAQGDVTTLIASPIAATLLGLAAA
ALIVPILMRRYGRGDILVKIAADED

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server